Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The implication of IL-6 in the invasiveness and chemoresistance of ovarian cancer cells. Systematic review of its potential role as a biomarker in ovarian cancer patients
Izabela Szulc-Kiełbik, Michał Kiełbik, Marek Nowak, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2021) Vol. 1876, Iss. 2, pp. 188639-188639
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

The Role of IL-6 in Cancer Cell Invasiveness and Metastasis—Overview and Therapeutic Opportunities
Magdalena Rašková, Lukáš Lacina, Zdeněk Kejík, et al.
Cells (2022) Vol. 11, Iss. 22, pp. 3698-3698
Open Access | Times Cited: 124
Exosomes: A potential tool for immunotherapy of ovarian cancer
Xiangjin Gong, Hao Chi, Dorothee Franziska Strohmer, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 57
The Role of Cancer-Associated Fibroblasts in Ovarian Cancer
Mo Zhang, Zhixian Chen, Yan Wang, et al.
Cancers (2022) Vol. 14, Iss. 11, pp. 2637-2637
Open Access | Times Cited: 52
HNRNPC downregulation inhibits IL‐6/STAT3‐mediated HCC metastasis by decreasing HIF1A expression
Danfei Liu, Xiangyuan Luo, Meng Xie, et al.
Cancer Science (2022) Vol. 113, Iss. 10, pp. 3347-3361
Open Access | Times Cited: 43
Interleukin-6 serves as a critical factor in various cancer progression and therapy
Asma’a H. Mohamed, Abdulrahman T. Ahmed, Waleed Al Abdulmonem, et al.
Medical Oncology (2024) Vol. 41, Iss. 7
Closed Access | Times Cited: 13
Single-Cell RNA Sequencing in Ovarian Cancer: Current Progress and Future Prospects
Zhi Xiong Chong
Progress in Biophysics and Molecular Biology (2025)
Closed Access | Times Cited: 1
Inflammation and Immune Escape in Ovarian Cancer: Pathways and Therapeutic Opportunities
Chunyan Liu, Qinan Yin, Zhaoying Wu, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 895-909
Open Access | Times Cited: 1
Cell Migration in Endometriosis Responds to Omentum-Derived Molecular Cues Similar to Ovarian Cancer
Kah Yee Goh, Su Chin Tham, Terence You De Cheng, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 1822-1822
Open Access | Times Cited: 1
Tumors and Cytomegalovirus: An Intimate Interplay
Georges Herbein
Viruses (2022) Vol. 14, Iss. 4, pp. 812-812
Open Access | Times Cited: 36
Malnutrition, sarcopenia, and cancer cachexia in gynecologic cancer
Molly Morton, Jenna M. Patterson, Jessica Sciuva, et al.
Gynecologic Oncology (2023) Vol. 175, pp. 142-155
Closed Access | Times Cited: 21
Interleukin-6 in Hepatocellular Carcinoma: A Dualistic Point of View
Iuliana Nenu, Teodora Maria Toadere, Ioan Topor, et al.
Biomedicines (2023) Vol. 11, Iss. 10, pp. 2623-2623
Open Access | Times Cited: 16
Ovarian cancer ascites confers platinum chemoresistance to ovarian cancer cells
Yifat Koren Carmi, Abed Agbarya, Hazem Khamaisi, et al.
Translational Oncology (2024) Vol. 44, pp. 101939-101939
Open Access | Times Cited: 5
Targeting interleukin-6 as a treatment approach for peritoneal carcinomatosis
Neda Dadgar, Christopher Sherry, Jenna Zimmerman, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Basal cell adhesion molecule (BCAM) promotes mesothelial-to-mesenchymal transition and tumor angiogenesis through paracrine signaling
Suresh Sivakumar, Sonja Lieber, Raimund Dietze, et al.
Cell Communication and Signaling (2025) Vol. 23, Iss. 1
Open Access
In silico docking, ADMET profiling, and bio-accessibility experimentation on Breynia retusa phytocompounds and in vitro validation for anti-proliferative potencies against ovarian carcinoma
Benedict Mathews Paul, Vetri Velavan Sundararajan, Francis Jegan Raj, et al.
3 Biotech (2025) Vol. 15, Iss. 5
Closed Access
Emerging perspectives on growth factor metabolic relationships in the ovarian cancer ascites environment
Mehri Monavarian, Amal Elhaw, Priscilla W. Tang, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 709-719
Open Access | Times Cited: 18
Redox-Regulated Iron Metabolism and Ferroptosis in Ovarian Cancer: Molecular Insights and Therapeutic Opportunities
Dan Liu, Zewen Hu, Jinzhi Lu, et al.
Antioxidants (2024) Vol. 13, Iss. 7, pp. 791-791
Open Access | Times Cited: 3
Evolution of tumor stress response during cytoreductive surgery for ovarian cancer
Aaron Praiss, Lea A. Moukarzel, Yingjie Zhu, et al.
iScience (2025), pp. 112317-112317
Open Access
The potential role of interleukins and interferons in ovarian cancer
Huldani Huldani, Sana Ali, F. Al-dolaimy, et al.
Cytokine (2023) Vol. 171, pp. 156379-156379
Closed Access | Times Cited: 8
Current State of Knowledge on Blood and Tissue-Based Biomarkers for Opisthorchis viverrini-induced Cholangiocarcinoma: A Review of Prognostic, Predictive, and Diagnostic Markers
Alok Kafle, Sutas Suttiprapa
Asian Pacific Journal of Cancer Prevention (2024) Vol. 25, Iss. 1, pp. 25-41
Open Access | Times Cited: 2
Comparison of Interleukin-6 with Other Markers in Diagnosis of Ovarian Cancer
Magdalena Bizoń, Zofia Awiżeń-Panufnik, Włodzimierz Sawicki
Journal of Personalized Medicine (2023) Vol. 13, Iss. 6, pp. 980-980
Open Access | Times Cited: 5
Anti-Tumor Effect of Turandot Proteins Induced via the JAK/STAT Pathway in the mxc Hematopoietic Tumor Mutant in Drosophila
Yuriko Kinoshita, Naoka Shiratsuchi, Mayo Araki, et al.
Cells (2023) Vol. 12, Iss. 16, pp. 2047-2047
Open Access | Times Cited: 5
Secreted Soluble Factors from Tumor-Activated Mesenchymal Stromal Cells Confer Platinum Chemoresistance to Ovarian Cancer Cells
Yifat Koren Carmi, Hazem Khamaisi, Rina Adawi, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 7730-7730
Open Access | Times Cited: 4
Integrated pipeline for ultrasensitive protein detection in cancer nanomedicine
Chi‐An Cheng, Li‐Chiao Chiang, Yu-Syuan Chu
RSC Advances (2023) Vol. 13, Iss. 21, pp. 14685-14697
Open Access | Times Cited: 4
Exploration of anti‑osteosarcoma activity of asiatic acid based on network pharmacology and in vitro experiments
He Pang, Hang Wu, Zeyu Zhan, et al.
Oncology Reports (2023) Vol. 51, Iss. 2
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top